Market revenue in 2023 | USD 82.7 million |
Market revenue in 2030 | USD 131.2 million |
Growth rate | 6.8% (CAGR from 2023 to 2030) |
Largest segment | Coronary stents |
Fastest growing segment | Accessory Devices |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Intravascular Imaging Catheters and Pressure Guidewires, Coronary Stents, PTCA Balloon Catheters, Accessory Devices |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Koninklijke Philips NV, Cardinal Health Inc, Terumo Corp, Teleflex Inc, B. Braun, Biosensors, BIOTRONIK, Asahi Intecc Co Ltd, Cook Medical, Merit Medical Systems Inc, Haemonetics Corp, Vascular Solutions, Zeon Corp, Alvimedica, Meril Life, Medinol |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to interventional cardiology devices market will help companies and investors design strategic landscapes.
Coronary stents was the largest segment with a revenue share of 50.79% in 2023. Horizon Databook has segmented the Norway interventional cardiology devices market based on intravascular imaging catheters and pressure guidewires, coronary stents, ptca balloon catheters, accessory devices covering the revenue growth of each sub-segment from 2018 to 2030.
The reimbursement scenario for cardiovascular devices in Norway is regulated by the Norwegian Directorate of Health and the Norwegian Medicines Agency. The reimbursement process involves a thorough evaluation of the clinical and economic evidence for medical devices.
If a device is deemed effective and cost-effective, it is included in the Norwegian List of Reimbursable Medicines and Medical Devices (LEK), which determines their reimbursement rates. The regulatory framework for cardiovascular devices in Norway is governed by the Norwegian Medicines Agency.
The agency is responsible for ensuring the safety, efficacy, and quality of medical devices, including cardiovascular devices. The Medical Device Act and associated regulations provide the legal framework for the approval and monitoring of medical devices in Norway.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway interventional cardiology devices market , including forecasts for subscribers. This country databook contains high-level insights into Norway interventional cardiology devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account